Business Description
Nuformix plc is a London-based drug development company focused on finding new uses for existing medicines to treat cancer and scarring diseases of the lung. Its pipeline includes three programs at various stages of development, targeting areas such as cancer patient care, pulmonary fibrosis, and a reformulated cancer treatment. The company holds a licensing agreement with Oxilio Ltd. covering one of its lead cancer-related programs.
